Protease-sparing regimen, often abbreviated as PSR, is a method or therapy for treating people infected with HIV that involves a three-drug combination that reduces viral load below the limit of detection while saving protease inhibitors for later use. It is considered a weaker (in terms of quantity and concentration) form of HIV treatment. It has been argued that such a regimen is not as potent as giving HIV patients with the strongest drugs as soon as it is detected. Others believe that this might be considered a long-term strategy in order to reduce the amount of HIV, and in some instances have proven to be successful.
See also Protease Women's Interagency HIV Study
References
External links "Protease Sparing Regimen in a Real Life Practice with Naive Patients: An Equal Opportunity Approach?". 13th International AIDS Conference. Durban, South Africa. July 9–14, 2000. WePeB4134. Archived from the original on 2007-09-30. Retrieved 2007-04-17. http://www.aids-ed.org/aidsetc?page=et-14-00-02 http://www.medscape.com/viewarticle/418668
